Madrigal: Rezdiffra Shift To F4c MASH Cirrhosis Continues With 2-Year Data

Rezdiffra FDA approval fuels sales; expansion to F4 MASH cirrhosis with 2027 trial data. Read more about MDGL stock here.

Midjourney’s New Scroll-Based Style Tool : Pins, Small Grids, and Reversed Order

Get a quick guide to Midjourney’s new style scroller, with reversed top-to-bottom results, so you can pick winners faster and ...

New AI tech can now spot dementia and fold your washing at CES 2026

A watch that can potentially identify early signs of dementia, a toothbrush that can smell diabetes and a robot that can fold ...
Everyday Health on MSN

We tested 19 vitamin C serums. Here are our favorites for gorgeous, glowing skin

Vitamin C is wonderful, says Angela Lamb, MD, a dermatologist and associate professor at the Icahn School of Medicine at Mount Sinai in New York City. Its good for targeting brown spots because it has ...
Parade on MSN

9 pore minimizers that actually work, according to dermatologists

Nightly use is a good idea for more serious pore concerns. "If you're using a strong pore minimizer, they do behave as ...
TheTechBoy

Samsung's A17 and A11+ Raise Questions Samsung Needs To Answer

However Samsung kept whittling it down even stripping the slot from the A5,3 series of devices leaving the slot on the A16.